US 10774333
Modulators of PNPLA3 expression
granted A61PA61P1/16
Quick answer
US patent 10774333 (Modulators of PNPLA3 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P1/16